Retinopathy of prematurity is an eye condition affecting babies born too early, where abnormal blood vessels develop in the retina, sometimes threatening vision or leading to blindness if not detected and treated in time.

Understanding the Prognosis: What to Expect

When a baby is diagnosed with retinopathy of prematurity, also known as ROP, it’s natural for parents to feel worried about what lies ahead. Understanding the outlook for this condition can help ease some of that anxiety, though every baby’s journey is unique and depends greatly on how severe the ROP becomes and how quickly it is caught.

The good news is that most babies with ROP have a very positive outlook. Up to 90% of infants diagnosed with ROP have mild forms that resolve on their own without any treatment at all, and these children go on to have normal vision.^[1][2] For these babies, the abnormal blood vessels that initially formed simply stop growing abnormally and the retina develops properly over time. This means that the vast majority of premature infants who develop ROP will not experience lasting vision problems from the condition itself.

However, ROP exists on a spectrum, with five different stages ranging from very mild to very severe. Babies in stages 1 and 2 typically get better without treatment and develop healthy vision. Some babies who reach stage 3 also improve without intervention, though others at this stage need treatment to prevent the abnormal blood vessels from damaging the retina, which is the light-sensitive tissue at the back of the eye that allows us to see.^[1] When treatment is needed and given promptly, the chances of preserving good vision are quite high.

The more serious stages—4 and 5—involve partial or complete retinal detachment, where the retina pulls away from its normal position. Even with treatment, babies in these advanced stages may experience vision loss or blindness. This is why early detection and timely treatment at stage 3 are so critical. Treatment at stage 3 aims to stop the disease from progressing to these more dangerous stages where permanent damage becomes much more likely.^[1]

In the United States, about 14,000 to 16,000 babies develop ROP each year. Of these, approximately 90% have mild disease that doesn’t require treatment. Only about 1,100 to 1,500 babies develop ROP severe enough to need medical intervention, and between 400 and 600 infants per year become legally blind from ROP despite available treatments.^[2][6] These numbers underscore both the general hopefulness of the prognosis for most babies and the critical importance of screening and monitoring for those at risk.

It’s also important to understand that even babies whose ROP resolves may face increased risks for other vision problems as they grow. Children who had ROP are more likely to develop nearsightedness, crossed eyes, amblyopia (often called lazy eye), and even retinal detachment later in life.^[1][9] This means that ongoing eye care and regular checkups throughout childhood remain important, even after the immediate threat from ROP has passed.

For parents, understanding these statistics and possibilities helps frame realistic expectations. While the diagnosis can be frightening, remember that most babies do very well. The key factors that influence your child’s outcome include how premature they were at birth, their birth weight, the stage at which ROP is detected, and whether timely treatment is given when needed. Modern screening programs and advanced treatments have dramatically improved outcomes for babies with ROP, giving most of them an excellent chance at healthy vision.^[10]

How ROP Develops Without Treatment

Understanding how retinopathy of prematurity progresses naturally helps parents grasp why screening and monitoring are so crucial. The disease follows a somewhat predictable pattern, though the speed and severity of progression vary considerably from baby to baby.

In a normal pregnancy, blood vessels in the baby’s retina begin developing around the fourth month of pregnancy and don’t finish growing until shortly before or at the time of birth.^[1] When a baby is born prematurely, this process is interrupted. The blood vessels haven’t yet completed their journey across the entire retina, leaving portions of this vital tissue without the blood supply it needs to function properly.

After premature birth, something changes in how these retinal blood vessels grow. Instead of continuing their normal, orderly development, they may begin growing abnormally. The vessels can become fragile and disorganized, growing in the wrong direction—sometimes even growing up from the surface of the retina into the gel-like substance inside the eye called the vitreous humor.^[4] This abnormal growth defines the early stages of ROP.

In stage 1, doctors can see a faint line on the retina that separates the area with normal blood vessels from the area where vessels are still developing abnormally. Many babies never progress beyond this point, and the condition resolves on its own. In stage 2, that line becomes a ridge with actual height and thickness. Again, many babies stabilize here and the condition improves without intervention.^[6]

If ROP continues to worsen without treatment, stage 3 brings the growth of new, abnormal blood vessels on the retina. These vessels are particularly fragile and prone to leaking or bleeding. The presence of what doctors call “plus disease”—where the retinal blood vessels become thick, twisted, and engorged—signals that the condition is becoming more serious and treatment may be needed soon.^[6]

Beyond stage 3, if left untreated, ROP enters its most dangerous phases. The abnormal blood vessels and the scar tissue that forms around them begin to contract, pulling on the retina. In stage 4, this pulling causes partial retinal detachment, where portions of the retina lift away from the back wall of the eye. By stage 5, the retina has completely detached.^[1] Once detachment occurs, the retina can no longer function properly, and vision loss or blindness results.

The timeframe for this progression varies. Some babies move rapidly from mild to severe stages, while others plateau at early stages and then improve. This unpredictability is exactly why repeated eye examinations are scheduled at specific intervals for at-risk babies. Doctors cannot predict which babies will progress and which will stabilize, so careful monitoring allows them to catch dangerous progression before permanent damage occurs.

An important aspect of natural progression is that it happens silently. Babies show no outward signs of ROP. They don’t appear to be in pain, their eyes don’t look different, and they behave normally. This invisible progression makes screening programs absolutely essential—there is simply no way for parents or even experienced healthcare providers to know ROP is worsening without specialized eye examinations using specific equipment and techniques.^[2]

Possible Complications That May Arise

Beyond the immediate concern of abnormal blood vessel growth, retinopathy of prematurity can lead to several complications that affect both the eyes themselves and a child’s developing vision. Understanding these potential complications helps parents know what to watch for and why ongoing care matters.

The most serious and immediate complication is retinal detachment. This occurs when the scar tissue formed by abnormal blood vessels contracts and pulls the retina away from the back of the eye. Retinal detachment is an emergency situation because the retina cannot function when separated from its blood supply and supporting structures. Even with surgical intervention, retinal detachment often results in significant vision loss.^[1][3] This is why treatment aims to prevent detachment before it happens.

Before actual detachment occurs, the fragile abnormal blood vessels characteristic of ROP can leak fluid or bleed into the eye. When bleeding occurs within the vitreous humor—the clear gel filling the eye—it can cause swelling and clouding that interferes with vision. While some bleeding may resolve on its own, significant hemorrhages can lead to scar tissue formation, which increases the risk of later retinal detachment.^[10]

Even when ROP resolves successfully, either on its own or with treatment, children face increased risks for other vision problems as they grow. Nearsightedness, also called myopia, is significantly more common in children who had ROP. This occurs because the eye’s shape may develop abnormally due to the early disruption in blood vessel growth. These children often need glasses at younger ages than their peers.^[1]

Crossed eyes, medically known as strabismus, is another complication seen more frequently in children with a history of ROP. This happens when the muscles controlling eye movement don’t work together properly, causing the eyes to point in different directions. Strabismus can affect depth perception and, if not treated, may lead to amblyopia.^[1]

Amblyopia, or lazy eye, develops when the brain begins favoring one eye over the other because the images from the two eyes are too different. If one eye has worse vision due to ROP-related damage or complications, the brain may start ignoring signals from that eye. Without treatment, the brain’s visual pathways for the ignored eye may not develop properly, leading to permanent vision reduction in that eye even if the eye itself is structurally intact.^[1]

Later in childhood or even in adulthood, people who had ROP remain at higher risk for retinal detachment than those who never had the condition. This means that even after successfully navigating the immediate threats of ROP in infancy, these individuals need to remain vigilant about eye health throughout their lives and seek immediate care if they experience symptoms like sudden flashes of light, new floaters, or a curtain-like shadow in their vision.^[1]

There are also developmental concerns that can arise when vision is significantly impaired. Vision plays a crucial role in how babies and young children learn about their world, develop coordination, and interact socially. When ROP causes vision loss, it can affect developmental milestones and require additional support services to help the child develop optimally despite visual limitations.

Impact on Daily Life and Development

Retinopathy of prematurity affects families in ways that extend far beyond medical appointments and treatments. The condition influences daily routines, emotional well-being, and long-term planning for the child’s development and education.

For infants still in the neonatal intensive care unit, the frequent eye examinations required for ROP screening can be stressful for parents to witness. During these exams, the eye doctor dilates the baby’s pupils with eye drops, which can cause temporary discomfort. The examination itself, while not painful, often makes babies cry because a small device holds the eyelids open and the doctor examines the retina carefully.^[9] Parents may find these necessary procedures emotionally difficult, even when they understand their importance. Having a nurse or family member present for support can help.

If treatment becomes necessary, families face additional stress and uncertainty. Treatment procedures like laser therapy or eye injections are typically performed in the hospital. While these interventions are usually safe and effective, the recovery period requires close monitoring. Babies may have red or puffy eyes for a few days after laser surgery, though they typically don’t experience significant pain. NICU nurses are trained to manage any discomfort, but parents naturally worry about their baby’s well-being during this time.^[9]

Once babies go home, the schedule of follow-up appointments continues. These visits are crucial for monitoring the eyes as they continue developing, but they add to the already complex medical schedule many premature infants require. Coordinating multiple specialist appointments while caring for a baby who may have other health concerns related to prematurity can be exhausting for families. Transportation, time off work, and childcare for siblings all become logistical challenges.

For children whose ROP results in vision impairment, daily life involves additional considerations. Parents may notice that their child’s eyes move unusually, wander, or don’t follow objects smoothly. The child may have trouble recognizing faces or may not respond to visual cues as expected. These signs can be emotionally difficult for parents and may require adjustments in how they interact with and stimulate their child.^[1]

If vision loss is significant, early intervention services become important. These services help children develop skills using their other senses and teach families techniques for supporting their child’s development. Occupational therapists, vision specialists, and developmental specialists may all become part of the child’s care team. While these services are valuable, they also mean more appointments and more coordination for already stretched families.

As children with ROP history grow older, they need ongoing eye care that may be more frequent and intensive than for other children. Regular examinations to check for complications like nearsightedness, crossed eyes, or retinal problems continue throughout childhood. Some children need glasses at young ages, which brings its own challenges of keeping glasses on an active toddler and dealing with the cost of replacement pairs.^[1]

School presents additional considerations for children who had severe ROP or resulting vision problems. They may need accommodations like preferential seating near the front of the classroom, large-print materials, or assistive technology. Teachers and school staff need to understand the child’s visual limitations and how to support their learning effectively.

The emotional and social impact shouldn’t be overlooked. Parents often experience anxiety, especially in the early months when ROP is being monitored or treated. They may feel guilty, wondering if something they did or didn’t do contributed to their baby’s condition, even though ROP is primarily related to prematurity itself. Support from family, friends, and parent support groups can help families process these difficult emotions.

For families facing severe outcomes like significant vision loss or blindness, grief is a natural response. Parents grieve for the vision their child won’t have and the challenges they know lie ahead. At the same time, they’re learning to care for and bond with their baby. This complex emotional landscape requires patience, support, and often professional counseling.

Siblings may also be affected, especially if parental attention is heavily focused on the baby with ROP and their medical needs. Finding ways to maintain family routines and give attention to all children becomes important for family well-being.

Despite these challenges, many families find strengths they didn’t know they had. They become advocates for their children, experts in their care, and connected to supportive communities of other families facing similar experiences. Children with vision impairment can thrive with appropriate support, reaching developmental milestones and living full, rich lives.

Supporting Families Through Clinical Trial Participation

Clinical trials play an essential role in advancing our understanding of retinopathy of prematurity and developing better treatments. For families navigating this condition, understanding what clinical trials are and how they might be relevant can be valuable, though participation is always a personal choice that should be made carefully with full information.

Clinical trials are research studies that test new ways to prevent, detect, or treat diseases. In the context of ROP, trials might investigate new medications, different treatment techniques, improved screening methods, or ways to predict which babies are most likely to develop severe disease. These studies are carefully designed and monitored to ensure participant safety while gathering important information that could help future babies with ROP.

For families considering clinical trial participation for their baby, the first step is understanding what the specific trial involves. Researchers are required to explain the study’s purpose, what procedures will be performed, any potential risks and benefits, and what alternatives exist. This information is provided through a detailed consent process, and families should never feel rushed into making a decision. Taking time to read materials carefully, ask questions, and discuss with family members and your baby’s regular healthcare team is completely appropriate.

It’s important to understand that participating in a clinical trial doesn’t mean giving up your baby’s regular care. Trial participation happens in addition to standard medical treatment, not instead of it. In fact, babies enrolled in clinical trials often receive even more intensive monitoring than they would otherwise, since research protocols typically include frequent assessments and close follow-up. Your baby’s eye doctor and other healthcare providers remain involved in their care throughout any trial participation.

Families should know that they can withdraw from a clinical trial at any time, for any reason, without any negative impact on their baby’s regular medical care. This right to withdraw is fundamental to ethical research, and families should never feel pressured to continue if they become uncomfortable with any aspect of the study.

When considering a clinical trial, families often wonder whether their baby will receive the experimental treatment or a placebo (an inactive substitute). In ROP trials, if an effective treatment already exists for the baby’s stage of disease, ethical standards require that the baby receive at least that standard treatment. Trials might compare a new treatment against the current standard, but babies wouldn’t be left untreated if treatment is indicated. For babies with mild ROP where standard care is observation, a trial might test a new preventive treatment versus continued observation.

Relatives and family members can play important supportive roles when a baby is enrolled in a clinical trial. They can attend appointments together, help keep track of the research schedule, and assist in observing and reporting any changes in the baby’s condition. Having an extra set of ears during research discussions can also be helpful, as medical information is often complex and easier to process when multiple people hear it.

Finding appropriate clinical trials for ROP involves asking your baby’s eye doctor or neonatologist if any trials are currently enrolling at your hospital or nearby facilities. Medical centers that specialize in neonatal care and pediatric ophthalmology are most likely to have active ROP research. Online registries of clinical trials are also available, though interpreting the technical information and eligibility criteria often requires help from your healthcare team.

Transportation, time, and additional appointments can all be barriers to clinical trial participation, especially for families who may already be stretched thin managing a premature baby’s care. Some research studies provide support like gas cards or meal vouchers to help offset these costs, though this varies by study. It’s appropriate to ask what support is available and to consider whether your family has the practical resources to manage the additional commitments.

Some families find meaning and purpose in contributing to research that might help other babies in the future, even if their own child may not directly benefit from the experimental approach. Others feel that the added complexity of trial participation is more than they can manage during an already stressful time. Both perspectives are completely valid, and the decision should be based on what feels right for your specific family and circumstances.

If your baby has already completed treatment for ROP or has grown beyond the infant stage, there may still be opportunities to contribute to research through long-term follow-up studies. These studies track outcomes over months or years to understand how early treatments affect vision and development over time. This type of research is valuable and often involves less intensive participation, such as annual vision assessments.